| Literature DB >> 20875287 |
Shawn Vasoo1, Kamaljit Singh, Gordon M Trenholme.
Abstract
In the absence of established guidelines for hospitalization of patients with pandemic (H1N1) 2009, we studied emergency department patients to identify clinical parameters that predict need for hospitalization. Independent predictors of hospitalization include multiple high-risk medical conditions, dyspnea, and hypoxia. These findings are easily applicable, with a 79% positive predictive value for hospitalization.Entities:
Mesh:
Year: 2010 PMID: 20875287 PMCID: PMC3294388 DOI: 10.3201/eid1610.091889
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Demographics of nonhospitalized and hospitalized patients who had pandemic (H1N1) 2009 infection, Rush University Medical Center, Chicago, Illinois, USA, April 29–June 22, 2009*
| Characteristic | Nonhospitalized patients, n = 51 | Hospitalized patients, n = 32 | ICU patients, n = 16 | Nonhospitalized vs. hospitalized patients | ICU vs. non–ICU patients† | |||
|---|---|---|---|---|---|---|---|---|
| p value | OR (95% CI) | p value | OR (95% CI) | |||||
| Median age, y (IQR) | 20.0 (9.0–28.0) | 12.0 (2.0–38.8) | 2.5 (1.13–31.8) | 0.70‡ | – | 0.16‡ | – | |
| Age <5 y, no. (%) | 8 (15.7) | 12 (37.5) | 9 (56.3) | 0.02§ | 3.2 (1.1–9.1) | 0.002 | 6.6 (2.0–21.3) | |
| Sex, M/F (% M) | 23/28 (45.1) | 12/20 (37.5) | 5/11 (31.3) | 0.50§ | 0.73 (0.30–1.8) | 0.33§ | 0.56 (0.18–1.8) | |
| Presence of high- risk conditions,¶ no. (%) | 21 (41.2) | 29 (90.6) | 16 (100) | <0.0001§ | 13.8 (3.7–51.3) | <0.0001 | – | |
| No. high-conditions per patient,¶ median (range) | 0 (0–2) | 2 (0–4) | 2 (1–3) | <0.0001‡# | – | <0.0001‡ | – | |
| Chronic pulmonary disease, no. (%) | 11 (21.6) | 13 (40.6) | 9 (56.3) | 0.06§ | 2.5 (0.94–6.6) | 0.01 | 4.5 (1.4–14.0) | |
| History of prematurity, no. (%) | 0 | 6 (18.8) | 5 (31.3) | 0.002 | – | 0.001 | 30.0 (3.2–281.8) | |
| Congenital heart disease,** no. (%) | 0 | 2 (6.3) | 2 (12.5) | 0.15 | – | 0.04 | – | |
| Transplantation,†† no. (%) | 1 (2.0) | 3 (9.4) | 1 (6.3) | 0.29 | 5.2 (0.51–52.1) | 1.00 | 1.4 (0.14–14.6) | |
| Hemoglobinopathy, no. (%) | 0 | 4 (12.5) | 2 (12.5) | 0.02 | – | 0.17 | 4.6 (0.6–35.8) | |
| Diabetes mellitus, no. (%) | 3 (5.9) | 5 (15.6) | 3 (18.8) | 0.25 | 3.0 (0.66–13.4) | 0.18 | 2.9 (0.6–13.5) | |
| Chronic neurologic disease | 2 (3.9) | 7 (21.9) | 4 (25.0) | 0.02 | 6.9 (1.3–35.5) | 0.07 | 4.1 (1.0–17.7) | |
| Immunosuppression, no. (%) | 2 (3.9) | 5 (15.6) | 3 (18.8) | 0.10 | 4.5 (0.82–25.0) | 0.13 | 3.6 (0.7–18.2) | |
| Malignancy, no. (%) | 0 | 3 (9.4) | 1 (6.3) | 0.054 | – | 0.48 | 2.2 (0.2–25.5) | |
| Pregnancy, no. (%)‡‡ | 1 (4) | 3 (15.0) | 0 | 0.29 | 4.8 (0.46–49.6) | 0.56 | – | |
*p values by Fisher exact test except as indicated. ICU, intensive care unit; OR, odds ratio; CI, confidence interval; IQR, interquartile range; –, not applicable. †Nonhospitalized patients + hospitalized patients not in ICU; n = 67. ‡Mann-Whitney U test. §Pearson 2-sided χ2 test. ¶High-risk conditions as defined by Centers for Disease Control and Prevention: <5 y or >65 y; pregnancy; immunosuppression; chronic pulmonary, cardiovascular, hepatic, hematologic, neurologic, neuromuscular, or metabolic disorders; long-term aspirin therapy in those <18 y of age. #Significant on multivariate analysis. **Tetralogy of Fallot (1), patent ductus arteriosus status postmedical closure (1). †† Renal transplant (2), liver transplant (1), heart transplant (1). ‡‡Percentage of female patients.
Clinical characteristics of nonhospitalized and hospitalized patients who had pandemic (H1N1) 2009 infection, Rush University Medical Center, Chicago, Illinois, USA, April 29–June 22, 2009*
| Characteristic | Nonhospitalized patients, n = 51 | Hospitalized patients, n = 32 | ICU patients, n = 16 | Nonhospitalized vs. hospitalized patients | ICU vs. non–ICU patients† | |||
|---|---|---|---|---|---|---|---|---|
| p value | OR (95% CI) | p value | OR (95% CI) | |||||
| Duration of ILI before evauulation, d, median (range) | 2 (0–7) | 3 (1–7) | 3 (1–7) | 0.15‡ | – | 0.20‡ | – | |
| Subjective fever, no. (%) | 46 (90.2) | 27 (84.4) | 14 (87.5) | 0.50 | 0.59 (0.16–2.2) | 1.00 | 0.95 (0.18–5.0) | |
| Headache, no. (%) | 18 (35.3) | 5 (15.6) | 1 (6.3) | 0.05§ | 0.34 (0.11–1.0) | 0.03 | 0.14 (0.02–1.1) | |
| Cough, no. (%) | 50 (98.0) | 25/31 (80.7) | 14 (87.5) | 0.01 | 0.08 (0.01–0.73) | 0.62 | 0.57 (0.10–3.3) | |
| Rhinorrhea, no. (%) | 40 (78.4) | 13/31 (41.9) | 7 (43.8) | 0.001§ | 0.20 (0.08-0.53) | 0.05§ | 0.34 (0.11–1.0) | |
| Sore throat, no. (%) | 24 (47.1) | 2/31 (6.5) | 1 (6.3) | <0.0001§ | 0.08 (0.02–0.36) | 0.02§ | 0.11 (0.01–0.88) | |
| Myalgia, no. (%) | 21 (41.2) | 6/31 (19.4) | 2 (12.5) | 0.04§ | 0.34 (0.12–0.98) | 0.053§ | 0.23 (0.05–1.1) | |
| Dyspnea, no. (%) | 2 (3.9) | 15 (46.9) | 11(68.8) | <0.0001§¶ | 21.6 (4.5–104.4) | <0.0001¶ | 22.4 (5.8–86.2) | |
| Nausea/vomiting, no. (%) | 14 (27.5) | 9/31 (29.0) | 4 (25.0) | 0.88§ | 1.1 (0.40–2.9) | 1.00 | 0.83 (0.24–2.9) | |
| Obesity (BMI | 12/37 (32.4) | 11/22 (50.0) | 4/10 (40.0) | 0.18§ | 2.1 (0.71–6.2) | 1.00 | 1.1 (0.26–4.2) | |
| Tachypnea, no. (%) | 9/49 (18.4) | 16/31 (51.6) | 10 (62.5) | 0.002§ | 4.7 (1.7–13.0) | 0.003§ | 5.4 (1.7–17.5) | |
| O2 saturation, % (range) | 99 (96–100) | 95 (65–100) | 92 (65–100) | <0.0001‡¶ | – | <0.0001‡¶ | – | |
| Hypoxia (SpO2
| 0 | 10 (31.3) | 9 (56.3) | <0.0001 | – | <0.0001 | 84.9 (9.3–772.0) | |
| Lymphopenia,# no. (%) | 9/12 (75.0) | 21 (65.6) | 10 (62.5) | 0.72 | 0.64 (0.14–2.80) | 0.54§ | 0.67 (0.18–2.5) | |
| Thrombocytopenia,# no. (%) | 1/12 (8) | 8 (25.0) | 5 (31.3) | 0.41 | 3.70 (0.41–33.00) | 0.25 | 2.7 (0.6–12.2) | |
| Acute renal failure,** no. (%) | 0 | 5 (15.6) | 4 (25.0) | 0.007 |
| 0.004 | 22.0 (2.3–214.2) | |
| Infiltrate on chest radiograph, no. (%) | 0 | 11/29 (37.9) | 11 (68.9) | 0.001 | – | <0.0001 | – | |
*p values by Fisher exact test except as indicated. Values given as no./no. indicate number of patients for whom results were available (if less than total no. patients in category). ICU, intensive care unit; OR, odds ratio; CI, confidence interval; ILI, influenza-like illness; –, not applicable; BMI, body mass index; SpO2, pulse oximeter oxygen saturation. †Nonhospitalized patients + hospitalized patients not in ICU; n = 67. ‡Mann-Whitney U test. §Pearson 2-sided χ2 test. ¶Significant on multivariate analysis. #Lymphopenia <1,500 lymphocytes/mm3, thrombocytopenia <150,000 thrombocytes/mm3. **Assuming that patients who did not have biochemical testing did not have acute renal failure.
Multiple logistic regression for risk factors associated with hospitalization for pandemic (H1N1) 2009 (nonhospitalized vs. hospitalized patients)*
| Variable | Coefficient (β) | SE | p value | OR (95% CI) |
|---|---|---|---|---|
| Intercept | 81.5 | 28.8 | – | – |
| No. high-risk conditions† | 1.24 | 0.48 | 0.01 | 3.44 (1.34–8.83) |
| Dyspnea | 3.09 | 1.20 | 0.01 | 22.00 (2.12–228.80) |
| O2 saturation | –0.86 | 0.30 | 0.004 | 0.42 (0.24–0.76) |
*OR, odds ratio; CI, confidence interval; O2 Saturation, oxygen saturation. Variables included in regression analysis: age <5 y, number of high-risk Centers for Disease Control and Prevention conditions, history of prematurity, hemoglobinopathy, or chronic neurologic disease, presence of dyspnea, tachypnea, oxygen saturation, and acute renal failure. Chest radiograph infiltrate was not included in the model because only half of the study received a chest radiograph. This model was well-fitted with a Hosmer-Lemeshow statistic of 0.773. †A high-risk condition as defined by the Centers for Disease Control and Prevention: age <5 y or >65 y; pregnancy; immunosuppression; chronic pulmonary, cardiovascular, hepatic, hematologic, neurologic, neuromuscular, or metabolic disorders; and long-term aspirin therapy in persons <18 y.
Multiple logistic regression for risk factors associated with ICU admission for pandemic (H1N1) 2009 (ICU patients vs. non-ICU study cohort)*
| Variable | Coefficient (β) | SE | p value | OR (95% CI) |
|---|---|---|---|---|
| Intercept | 44.2 | 20.6 | – | – |
| Dyspnea | 3.20 | 1.29 | 0.01 | 24.4 (1.95–305.4) |
| O2 saturation | –0.55 | 0.24 | 0.02 | 0.58 (0.36–0.92) |
*ICU, intensive care unit; OR, odds ratio; CI, confidence intervals; O2 saturation, oxygen saturation. Variables included in regression analysis: age <5 y, number of high-risk conditions per Centers for Disease Control and Prevention, history of prematurity, congenital heart disease or pulmonary disease, the presence of dyspnea, tachypnea, O2 saturation, and acute renal failure. Chest radiograph infiltrate was not included in the model because only half of the study cohort received a chest radiograph. This model was well-fitted with a Hosmer–Lemeshow statistic of 0.923.